Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025259 <b>Size:</b> 697 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025260 <b>Size:</b> 1 MB

New Form N-PX - ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000919574-26-005862 <b>Size:</b> 8 KB

New Form N-PX - ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000919574-26-005861 <b>Size:</b> 11 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025258 <b>Size:</b> 672 KB

La FDA aprueba Mounjaro (tirzepatida) de Lilly para reducir el riesgo cardiovascular en adultos con diabetes tipo 2

Change in holdings of interested parties/officers

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042081 <b>Size:</b> 540 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025257 <b>Size:</b> 939 KB

General Announcement: Proposed Transfer of Listing from the Mainboard to Catalist of the SGX-ST

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025256 <b>Size:</b> 1 MB

(99% Neutral) ALTRIA GROUP, INC. (MO) Files Form 8-K

New Form 424B3 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025255 <b>Size:</b> 1 MB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042080 <b>Size:</b> 584 KB

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025253 <b>Size:</b> 107 KB